Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00038688 · ClinicalTrials.gov registry record · Phase 3
A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts
A Phase 3 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 3
- Development phase
- 2,610
- Enrollment target
NCT00038688 is a Phase 3 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 2,610 participants.
The verdict
NCT00038688, a Phase 3 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,610 participants
- Enrollment target
Study Summary
Injection drug use is the major mode of HIV transmission in many countries. Injection drug users (IDUs) transmit HIV not only through shared drug injection equipment but also through heterosexual and homosexual transmission and mother-to-child transmission. Studies have shown that peer education programs can reduce HIV risk behavior in IDUs. However, it is not known if reduced HIV risk behavior leads to fewer HIV infections. The purpose of this study is to find out if a peer education program can reduce the number of new HIV infections by changing the behavior of IDUs and their HIV risk contacts.
Interventions
- BEHAVIORAL Peer HIV Education Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,610 participants |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00038688
The ClinicalTrials.gov registry entry for NCT00038688 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,610 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peer HIV Education Program is the first listed.
NCT00038688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00038688 about?
NCT00038688 is a clinical study titled "A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts". Injection drug use is the major mode of HIV transmission in many countries. Injection drug users (IDUs) transmit HIV not only through shared drug injection equipment but also through heterosexual and homosexual transmission and mother-to-child transmission. Studies have shown that peer education pro...
What is the current status of trial NCT00038688?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,610 participants.
What interventions are being tested in trial NCT00038688?
The interventions under investigation include: Peer HIV Education Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00038688?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.